How Governmental Policies Guided the Development of the Proposed Intervention

The HIPAA and the American Nurse Association guided the formulation of my intervention. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) provides guidelines to promote the effective use of health technology (Moore & Frye, 2019). The HIPAA advocates for privacy, confidentiality, and security when transmitting protected health information electronically (Moore & Frye, 2019). Protected health information includes biodata, presenting complaint, diagnosis, treatment plan, medication history, and history of presenting complaint (Moore & Frye, 2019).

The American Nurse Association (ANA) provides standards and policy guidelines that promote care coordination for all patients. ANA emphasizes the nursing process, cultural sensitivity, nursing ethics, and collaboration (ANA, n.d.). Cultural sensitivity promotes the recognition and respect of other people’s beliefs. By so doing, it increases access to care (ANA, n.d.). The nursing process enables the nurse to develop patient-centered care plans and conduct periodic evaluations.

My intervention entails using telehealth to promote medication adherence and lifestyle modification for patients with AD. This intervention is formulated to fulfill the provisions of HIPAA and the ANA. Telehealth technology, such as mobile health helps to improve medication adherence using features such as reminders, alarms, and messages (Maresova et al., 2018). Wearable devices facilitate remote patient monitoring, whereas video conferencing allows real-time interactions with patients (Maresova et al., 2018). Lifestyle modifications for people with AD include physical activity and dietary modification. Caprylidene is an example of a nutritional supplement for people with AD (Galvin et al., 2021). Physical activity minimizes the rate of brain atrophy and maintains hippocampal volume (Galvin et al., 2021). Additionally, exercise improves cardiorespiratory activity and averts comorbidities such as hypertension (Galvin et al., 2021). Medication adherence is associated with a good prognosis for patients with AD (Galvin et al., 2021).

Proposed Intervention and the Quality of Care, Patient Safety, Costs

My intervention entails using telehealth to promote medication adherence and lifestyle modification for a patient with AD. Telehealth technology helps to improve care coordination for patients with AD. This is accomplished via remote patient monitoring and flexibility in the access to healthcare services (Maresova et al., 2018). Telehealth improves medication adherence using mobile health features such as messages, reminders, and alarms (Maresova et al., 2018). Medication adherence is associated with a good prognosis of AD, hence patient safety (Galvin et al., 2021). Telehealth technology features such as audio and videoconferencing allow real-time interaction with the patient (Maresova et al., 2018). Healthcare practitioners make timely interventions and prevent the deterioration of the patient’s condition.

Maresova et al. (2018) report that telehealth technological features such as wearable devices and sensors allow healthcare practitioners to monitor the patient’s routine, including physical activity, sleep, and diet. Physical activity is useful for patients with mild to moderate AD because it prevents brain atrophy (Galvin et al., 2021). Medication adherence and lifestyle modification are associated with a good prognosis of AD (Galvin et al., 2021). This reduces the incidences of hospitalizations due to AD-related complications. By so doing, patients’ costs of managing AD are lowered.

Sources of Benchmark Data on Care Quality, Patient Safety, and Costs

The Alzheimer’s Association provides benchmark data on the quality of care, patient safety, and costs in the management of AD. This is accomplished via annual reports. The scope of the reports is the prevalence of AD in each state and nationally, the sociodemographic distributions of the prevalence of AD, mortalities related to AD, national costs in the management of AD, and public awareness (Alzheimer’s Association, n.d.).

Technology, Care Coordination, and the Utilization of Community Resources

According to Maresova et al. (2018), telehealth technology using mobile health, videoconferencing, wearable devices, and sensors can be used to manage AD. Mobile health provides features such as reminders and alarms that help to improve medication adherence (Maresova et al., 2018). Wearable devices and sensors enable healthcare practitioners to monitor the patient periodically (Maresova et al., 2018). Videoconferencing provides real-time patient interaction and facilitates timely interventions (Maresova et al., 2018).

Care coordination is accomplished by members of the interdisciplinary team. Nurses are involved